Market
Scenario
Cerebral palsy (CP) is a congenital disorder that affects the muscle
tone, movement, and motor skills. CP is generally considered to be caused by
brain damage that happens before or during the baby's birth. The signs and
symptoms of CP vary from person to person. According to the Centers for Disease
Control and Prevention (CDC), some of the signs and symptoms of clinical palsy
includes coordination and control problem, lack of muscle control, oral motor
problems, and abnormal reflex responses. Currently, there are a wide variety of
medications and therapies available to help people with cerebral palsy.
The
increasing prevalence of cerebral palsy coupled with increasing awareness about
the condition is anticipated to drive the global cerebral palsy market.
According to an article published by the National Center for Biotechnology
Information (NCBI) in 2017, the overall birth prevalence of cerebral palsy is
approximately 2 per 1,000 births worldwide. Moreover, the rising adoptions of
medications for controlling the symptoms of the cerebral palsy are expected to
boost the market growth. In addition, rising healthcare expenditure in
developed economies and increasing insurance coverage contributes to the growth
of the market during the assessment period. On the other hand, side effects
associated with medications and high treatment cost and lack of awareness in
some developing regions may hinder the growth of the market.
Despite
the drivers, side effects associated with medications and high treatment cost
and lack of awareness in some developing regions may hamper the market growth
during the assessment period.
Segmentation
The
global cerebral palsy market has been segmented into type, diagnosis, and
treatment.
The
market, on the basis of type, has been segmented into spastic cerebral palsy,
dyskinetic cerebral palsy, hypotonic cerebral palsy, ataxic cerebral palsy, and
mixed cerebral palsy.
The
market, by diagnosis, has been segmented into imaging tests and others. The imaging
tests have been further segmented into magnetic resonance imaging (MRI),
cranial ultrasound, computed tomography, and electroencephalogram.
The
market, by treatment, has been segmented into therapy, medication, surgery, and
others. The therapy segment has been segmented into nutrition therapy,
hyperbaric oxygen therapy, occupational therapy, physical therapy, stem cell
therapy, and others. The medication segment has been segmented into
anti-convulsant drugs, muscle relaxants, anti-depressant drugs, anti-inflammatory
drugs, and others. Further, the surgery segment has been segmented into
orthopedic surgery and others.
The
market has been segmented, by region, into the Americas, Europe, Asia-Pacific,
and the Middle East & Africa. The cerebral palsy market in the Americas has
further been segmented into North America and South America, with the North
American market divided into the US and Canada.
The
European cerebral palsy market has been segmented into Western Europe and
Eastern Europe. Western Europe has further been classified as Germany, France,
the UK, Italy, Spain, and the rest of Western Europe.
The
cerebral palsy market in Asia-Pacific has been segmented into Japan, China,
India, South Korea, Australia, and the rest of Asia-Pacific. The cerebral palsy
market in the Middle East & Africa has been segmented into the Middle East
and Africa.
Key
players
Allergen
Plc, Cellular Biomedicine Group, Merck & Co., Inc., Pfizer, Inc.,
GlaxoSmithKline Plc, Abbott Laboratories, Acorda Therapeutics, Inc., Medtronic,
Meridigen Biotech Co., Ltd., GW Pharmaceuticals Plc, and Cell Cure
Neurosciences Ltd. are some of the key players in the global cerebral palsy
market.
Regional
Market Summary
Geographically,
the Americas is anticipated to dominate the global cerebral palsy market owing
to a well-developed healthcare sector, rising prevalence of cerebral palsy and
growing healthcare expenditure. Additionally, favorable reimbursement scenario
in this region and a relatively large number of research and development (R&D)
activities contributes to the growth of the market.
Europe is
expected to hold the second largest position in the global cerebral palsy
market. The market growth in this region is attributed to the growing
prevalence of cerebral palsy, availability of funds for research, and
increasing healthcare expenditure. According to the data stated by the National
Institute for Health and Care Excellence (NICE) in 2017, in the UK, it is
estimated that 1 in 400 babies are born with cerebral palsy. It also stated that
approximately 1,800 children diagnosed with CP each year.
The
cerebral palsy market in Asia-Pacific region consists of countries namely
China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific.
Asia-Pacific is anticipated to be the fastest growing region in the market due
to the presence of a huge patient population, continuously developing
economies, rising prevalence of cerebral palsy and increasing government
funding for the healthcare sector.
On the
other hand, the Middle East & Africa has the least share of the market.
Majority of the market of this region is expected to be held by the Middle East
region due to a well-developed healthcare sector and growing government
initiatives for the healthcare sector.
Browse Complete 90 Pages Premium Research Report
Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/check-discount/6334
Detailed
Table of Contents:
1.
Report Prologue
2.
Market Introduction
2.1
Definition
2.2
Scope Of The Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
3.
Research Methodology
3.1
Introduction
3.2
Primary Research
3.3
Secondary Research
3.4
Market Size Estimation
List Of Tables and Figures
List Of Tables
Table 1 Global Cerebral Palsy Market Synopsis, 2018–2023
Table 2 Global Cerebral Palsy Market Estimates And Forecast,
2018–2023 (Usd Million)
Table 3 Global Cerebral Palsy Market, By Region, 2018–2023 (Usd
Million)
Table 4 Global Cerebral Palsy Market, By Type, 2018–2023 (Usd
Million)
Table 5 Global Cerebral Palsy Market, By Diagnosis,
2018–2023(Usd Million)
Table 6 Global Cerebral Palsy Market, By Treatment, 2018–2023
(Usd Million)
Table 7 North America: Cerebral Palsy Market, By Type, 2018–2023
(Usd Million)
List Of Figures
Figure 1 Research Process
Figure 2 Segmentation For Global Cerebral Palsy Market
Figure 3 Segmentation Market Dynamics For Global Cerebral Palsy
Market
Figure 4 Global Cerebral Palsy Market Share, By Type, 2017
Figure 5 Global Cerebral Palsy Market Share, By Diagnosis, 2017
Figure 6 Global Cerebral Palsy Market Share, By Treatment, 2017
Figure 7 Global Cerebral Palsy Market Share, By Region, 2017
...Continued
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment